Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TPF Induction Chemotherapy and Cetuximab in Head and Neck Cancer
NCT01181401Phase 2Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Aug 2010
- Primary completion
- Apr 2015
- Modality
- Antibody Conjugates, Monoclonal Antibodies, Engineered Antibody Formats
- Countries
- 1
01
Overview
A Phase 2 trial of cetuximab, docetaxel, cisplatin, fluorouracil in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Charité – Universitätsmedizin Berlin. Started Aug 2010; status: completed.
02
Drugs
cetuximabdocetaxelcisplatinfluorouracil
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01181401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01181401.